Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone vs Pioglitazone and Placebo in Type 2 Diabetes
NCT00297063Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2006
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rosiglitazone in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Jan 2006; status: completed.
02
Drugs
rosiglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00297063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00297063.